- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04895033
Brain Responses to Contextual Influences on Drinking Decisions
May 24, 2023 updated by: University of Kansas Medical Center
This study is using functional magnetic resonance imaging (fMRI) to examine brain activity associated with making decisions about drinking alcohol in everyday situations, some of which may involve important activities happening the next day.
The secondary aims are to determine whether severity of alcohol-related problems is related to brain activity and alcohol choices and to examine how different areas of the brain interact in connected networks.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The overall objective of this study is to examine brain activity associated with making decisions about drinking alcohol in everyday situations, some of which may involve important activities happening the next day.
The secondary aims are to determine whether severity of alcohol-related problems is related to brain activity and alcohol choices and to examine how different areas of the brain interact in connected networks.
The study involves two testing sessions -- a baseline interview conducted virtually or in-person, and a MRI scanning session at University of Kansas Medical Center.
Participants (N=80, 50% female, age 21-55) are community adults who report drinking alcohol in excess of NIAAA-recommended weekly drinking limits (i.e., heavy drinkers who consume 14/7+ drinks per week for men/women).
Participants will complete hypothetical alcohol purchase tasks during the MRI scan with two conditions being examined.
A control condition involves a typical drinking situation with no explicit responsibilities.
An experimental condition involves a hypothetical situation with important personally-relevant responsibilities the next day (e.g., a presentation at work, an exam, or caregiving responsibilities).
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Michael Amlung, PhD
- Phone Number: 785.864.0334
- Email: mamlung@ku.edu
Study Locations
-
-
Kansas
-
Lawrence, Kansas, United States, 66045
- Recruiting
- Cofrin Logan Center for Addiction Research and Treatment
-
Contact:
- Michael Amlung, PhD
- Phone Number: 785-864-0334
- Email: mamlung@ku.edu
-
Principal Investigator:
- Michael Amlung, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 53 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 21-55 years of age;
- current heavy alcohol drinking in the past three months, as indicated by reporting consumption of 14 or more drinks per week for men or 7 or more drinks per week for women and at least one heavy drinking episode weekly (5+/4+ drinks in a single occasion for males/females);
- belong to a category with significant responsibilities, such as being currently employed, a current student, or a caregiver with significant responsibilities;
- speak English;
- normal or corrected to normal vision and hearing;
- able to give informed consent.
Exclusion Criteria:
- currently engaged in treatment or seeking treatment for alcohol-related problems;
- major psychiatric illness (psychotic disorder, bipolar disorder, post-traumatic stress disorder);
- Diagnostic and Statistical Manual Version-5 substance use disorder (except nicotine);
- attending any in-person session with a positive breath alcohol concentration (BrAC > 0.00%);
- any contraindications for MRI scanning (e.g., metal in body surgically or accidentally including pacemaker, cochlear implants, aneurysm clips, shrapnel, etc.);
- history of seizures or anti-seizure medication;
- history of concussion or other significant brain injury;
- serious medical illness unsuitable for the MRI scanner based on best clinical judgment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Responsibility vs No Responsibility
Within-subjects experimental manipulation of responsibility vs. no-responsibility condition
|
During the fMRI scan, participants will complete alcohol purchase task paradigm for hypothetical alcohol rewards under two conditions.
In the next-day responsibility condition, we will present a vignette describing a drinking scenario in which participants have a significant activity the next day (e.g., a work, family, or academic obligation the next morning) and participants are asked to imagine they are deciding how much they want to drink in this situation.
The control condition will use a vignette describing a typical drinking scenario with no explicit responsibilities the next day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol demand
Time Frame: During 1 hour MRI scan
|
Participants will report how many standard drinks they would consume at varying prices using a hypothetical Alcohol Purchase Task (APT) procedure.
The APT is a validated self-report measure of alcohol consumption (in standard drink units) at escalating prices (18 price intervals, ranging from $0 to $80/drink).
Responses on APT are analyzed to generate observed and derived indices of alcohol demand, including: intensity (consumption at free price); breakpoint (maximum price for spent for a single drink); Omax (maximum expenditure on alcohol); and Elasticity (proportionate slope of the alcohol demand curve)
|
During 1 hour MRI scan
|
Brain activation
Time Frame: During 1 hour MRI scan
|
Blood-oxygen-level-dependent (BOLD) activity measured by functional magnetic resonance imaging
|
During 1 hour MRI scan
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Michael Amlung, PhD, University of Kansas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
July 31, 2024
Study Registration Dates
First Submitted
May 12, 2021
First Submitted That Met QC Criteria
May 12, 2021
First Posted (Actual)
May 20, 2021
Study Record Updates
Last Update Posted (Actual)
May 26, 2023
Last Update Submitted That Met QC Criteria
May 24, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00147117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
After the study is complete, the researchers are encouraged by NIH funding guidelines to deposit de-identified fMRI data and associated baseline data into a public access archive such as NeuroVault (https://neurovault.org/), a secure repository where researchers can publicly store and share unthresholded statistical maps, parcellations, and atlases produced by fMRI studies.
The investigators will take all necessary steps to ensure that only de-identified data is made publicly available.
IPD Sharing Time Frame
Data will be posted at conclusion of study
IPD Sharing Access Criteria
Data will be publicly available to researchers who create an account on neurovault.org
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
Boston University Charles River CampusRecruiting
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
University of ArkansasRecruitingDrinking Behavior | Drinking Excessive | DrinkingUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
University of North Texas Health Science CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Universidad de GranadaCompletedExercise | Drinking, AlcoholSpain
-
Lehigh UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Brown UniversityCompletedCollege DrinkingUnited States
Clinical Trials on Responsibility condition
-
Geisinger ClinicCompletedBehavior, HealthUnited States
-
Geisinger ClinicCompletedHealth BehaviorUnited States
-
Brigham and Women's HospitalNational Institute on Aging (NIA)Active, not recruitingAddressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes MedicationsDiabetes | SGLT-2i and GLP-1RA Therapies | Diffusion of Responsibility | Prescribing BurdenUnited States
-
Boston University Charles River CampusDeborah Munroe Noonan Memorial Research FundNot yet recruitingAutism Spectrum Disorder | Family Relations
-
Rutgers, The State University of New JerseyRecruitingAggression | Problem Behavior | Self InjuryUnited States
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH)CompletedPhysical Activity | Affect
-
University of LausanneEmpa - Swiss Federal Laboratories for Materials Testing and Research, ZürichCompleted
-
University of California, IrvineCompleted
-
Karadeniz Technical UniversityNot yet recruitingHealth, Subjective | Family Planning | Nurse | Women
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingGlucose Metabolism Disorders | Type 2 Diabetes | Glucose, High BloodUnited States